Merck and Orion Announce Global Collaboration for Oncology Drug July 25, 2022 AutoBot News 0 Merck, known as MSD outside the United States and Canada, and Orion Corporation are collaborating to develop and commercialize a treatment for metastatic castration-resistant prostate cancer.